Dose Optimization News Today

Experts say that Project Optimus is a necessary reform in the oncology space, but one that should be applied with caution.

A comprehensive discussion on approaches to optimizing treatment selection and dosing in HR+/HER2- breast cancer.

Poster Discussion Features Investigational Safety and Efficacy Data from the Platinum-Resistant Ovarian Cancer Cohort Expansion of a Phase 1 Study Evaluating Farletuzumab Ecteribulin (MORAb-202) in Solid

Press release content from PR Newswire. The AP news staff was not involved in its creation.

New EULAR points were developed by a multidisciplinary task force from eight European countries with health care professionals from various branches.